Is Vivos Therapeutics (VVOS) Worth a Shot?
Vivos Therapeutics (NASDAQ: VVOS) is one of those microcaps that drifts across your screen while you’re looking for the next healthcare breakout. It’s a company with an interesting niche—oral appliance therapy for obstructive sleep apnea (OSA)—and it’s cheap enough to tempt small-cap speculators. But cheap doesn’t always mean good. And “innovative device company” doesn’t always […]
Is Vivos Therapeutics (VVOS) Worth a Shot? Read More »